Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors (Englisch)
- Neue Suche nach: Tabernero, J.
- Neue Suche nach: Rojo, F.
- Neue Suche nach: Calvo, E.
- Neue Suche nach: Burris, H.
- Neue Suche nach: Judson, I.
- Neue Suche nach: Hazell, K.
- Neue Suche nach: Martinelli, E.
- Neue Suche nach: y Cajal, S.R.
- Neue Suche nach: Jones, S.
- Neue Suche nach: Vidal, L.
- Neue Suche nach: Tabernero, J.
- Neue Suche nach: Rojo, F.
- Neue Suche nach: Calvo, E.
- Neue Suche nach: Burris, H.
- Neue Suche nach: Judson, I.
- Neue Suche nach: Hazell, K.
- Neue Suche nach: Martinelli, E.
- Neue Suche nach: y Cajal, S.R.
- Neue Suche nach: Jones, S.
- Neue Suche nach: Vidal, L.
In:
JOURNAL OF CLINICAL ONCOLOGY
;
26
, 10
;
1603-1610
;
2008
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors
-
Beteiligte:Tabernero, J. ( Autor:in ) / Rojo, F. ( Autor:in ) / Calvo, E. ( Autor:in ) / Burris, H. ( Autor:in ) / Judson, I. ( Autor:in ) / Hazell, K. ( Autor:in ) / Martinelli, E. ( Autor:in ) / y Cajal, S.R. ( Autor:in ) / Jones, S. ( Autor:in ) / Vidal, L. ( Autor:in )
-
Erschienen in:JOURNAL OF CLINICAL ONCOLOGY ; 26, 10 ; 1603-1610
-
Verlag:
- Neue Suche nach: W B SAUNDERS CO
-
Erscheinungsdatum:01.01.2008
-
Format / Umfang:8 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.99
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.99 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 26, Ausgabe 10
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1573
-
Martin D. Abeloff, MDDavidson, N.E. et al. | 2008
- 1575
-
Breaking the Cure Barrier 25 Years LaterHolland, J.F. et al. | 2008
- 1576
-
Dose Selection in Phase I Studies: Why We Should Always Go for the TopSleijfer, S. / Wiemer, E. et al. | 2008
- 1579
-
Should Intravenous Iron Be the Standard of Care in Oncology?Auerbach, M. et al. | 2008
- 1582
-
Determinants of RASistance to Anti-Epidermal Growth Factor Receptor AgentsBaselga, J. / Rosen, N. et al. | 2008
- 1585
-
Optimal Schedule of Paclitaxel: Weekly Is BetterGonzalez-Angulo, A.M. / Hortobagyi, G.N. et al. | 2008
- 1588
-
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid TumorsO Donnell, A. / Faivre, S. / Burris, H.A. / Rea, D. / Papadimitrakopoulou, V. / Shand, N. / Lane, H.A. / Hazell, K. / Zoellner, U. / Kovarik, J.M. et al. | 2008
- 1596
-
Identifying Optimal Biologic Doses of Everolimus (RAD001) in Patients With Cancer Based on the Modeling of Preclinical and Clinical Pharmacokinetic and Pharmacodynamic DataTanaka, C. / O Reilly, T. / Kovarik, J.M. / Shand, N. / Hazell, K. / Judson, I. / Raymond, E. / Zumstein-Mecker, S. / Stephan, C. / Boulay, A. et al. | 2008
- 1603
-
Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid TumorsTabernero, J. / Rojo, F. / Calvo, E. / Burris, H. / Judson, I. / Hazell, K. / Martinelli, E. / y Cajal, S.R. / Jones, S. / Vidal, L. et al. | 2008
- 1611
-
Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced AnemiaBastit, L. / Vandebroek, A. / Altintas, S. / Gaede, B. / Pinter, T. / Suto, T.S. / Mossman, T.W. / Smith, K.E. / Vansteenkiste, J.F. et al. | 2008
- 1619
-
Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin AlfaPedrazzoli, P. / Farris, A. / Del Prete, S. / Del Gaizo, F. / Ferrari, D. / Bianchessi, C. / Colucci, G. / Desogus, A. / Gamucci, T. / Pappalardo, A. et al. | 2008
- 1626
-
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal CancerAmado, R.G. / Wolf, M. / Peeters, M. / Van Cutsem, E. / Siena, S. / Freeman, D.J. / Juan, T. / Sikorski, R. / Suggs, S. / Radinsky, R. et al. | 2008
- 1635
-
Complete Pathologic Response After Preoperative Chemotherapy for Colorectal Liver Metastases: Myth or Reality?Adam, R. / Wicherts, D.A. / de Haas, R.J. / Aloia, T. / Levi, F. / Paule, B. / Guettier, C. / Kunstlinger, F. / Delvart, V. / Azoulay, D. et al. | 2008
- 1642
-
Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840Seidman, A.D. / Berry, D. / Cirrincione, C. / Harris, L. / Muss, H. / Marcom, P.K. / Gipson, G. / Burstein, H. / Lake, D. / Shapiro, C.L. et al. | 2008
- 1650
-
Phase III Randomized Placebo-Controlled Trial of Two Doses of Megestrol Acetate as Treatment for Menopausal Symptoms in Women With Breast Cancer: Southwest Oncology Group Study 9626Goodwin, J.W. / Green, S.J. / Moinpour, C.M. / Bearden, J.D. / Giguere, J.K. / Jiang, C.S. / Lippman, S.M. / Martino, S. / Albain, K.S. et al. | 2008
- 1657
-
Clinical Classification of BRCA1 and BRCA2 DNA Sequence Variants: The Value of Cytokeratin Profiles and Evolutionary Analysis-A Report From the kConFab InvestigatorsSpurdle, A.B. / Lakhani, S.R. / Healey, S. / Parry, S. / Da Silva, L.M. / Brinkworth, R. / Hopper, J.L. / Brown, M.A. / Babikyan, D. / Chenevix-Trench, G. et al. | 2008
- 1664
-
Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor-Positive, Advanced Breast Cancer: Results From EFECTChia, S. / Gradishar, W. / Mauriac, L. / Bines, J. / Amant, F. / Federico, M. / Fein, L. / Romieu, G. / Buzdar, A. / Robertson, J.F.R. et al. | 2008
- 1671
-
Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast CancerDixon, J.M. / Renshaw, L. / Young, O. / Murray, J. / Macaskill, E.J. / McHugh, M. / Folkerd, E. / Cameron, D.A. / A Hern, R.P. / Dowsett, M. et al. | 2008
- 1677
-
Plasma Isoflavone Level and Subsequent Risk of Breast Cancer Among Japanese Women: A Nested Case-Control Study From the Japan Public Health Center-Based Prospective Study GroupIwasaki, M. / Inoue, M. / Otani, T. / Sasazuki, S. / Kurahashi, N. / Miura, T. / Yamamoto, S. / Tsugane, S. et al. | 2008
- 1684
-
Economic Evaluation Alongside a Clinical Trial of Psycho-Educational Interventions to Improve Adjustment to Survivorship Among Patients With Breast CancerMandelblatt, J.S. / Cullen, J. / Lawrence, W.F. / Stanton, A.L. / Yi, B. / Kwan, L. / Ganz, P.A. et al. | 2008
- 1691
-
Randomized Phase II Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin Plus Cyclophosphamide in Axillary Node-Positive Breast CancerPuhalla, S. / Mrozek, E. / Young, D. / Ottman, S. / McVey, A. / Kendra, K. / Merriman, N.J. / Knapp, M. / Patel, T. / Thompson, M.E. et al. | 2008
- 1698
-
Phase III Trial of Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care in Previously Treated Patients With Advanced Malignant Pleural MesotheliomaJassem, J. / Ramlau, R. / Santoro, A. / Schuette, W. / Chemaissani, A. / Hong, S. / Blatter, J. / Adachi, S. / Hanauske, A. / Manegold, C. et al. | 2008
- 1705
-
Concordance of Survival in Family Members With Prostate CancerHemminki, K. / Ji, J. / Forsti, A. / Sundquist, J. / Lenner, P. et al. | 2008
- 1710
-
Retrospective Study of Childhood GanglioneuromaDe Bernardi, B. / Gambini, C. / Haupt, R. / Granata, C. / Rizzo, A. / Conte, M. / Tonini, G.P. / Bianchi, M. / Giuliano, M. / Luksch, R. et al. | 2008
- 1717
-
Easing of Suffering in Children With Cancer at the End of Life: Is Care Changing?Wolfe, J. / Hammel, J.F. / Edwards, K.E. / Duncan, J. / Comeau, M. / Breyer, J. / Aldridge, S.A. / Grier, H.E. / Berde, C. / Dussel, V. et al. | 2008
- 1724
-
Physician-Identified Factors Affecting Patient Participation in Reaching Treatment DecisionsShepherd, H.L. / Tattersall, M.H.N. / Butow, P.N. et al. | 2008
- 1732
-
Phase I Study of Bevacizumab Added to Fluorouracil- and Hydroxyurea-Based Concomitant Chemoradiotherapy for Poor-Prognosis Head and Neck CancerSeiwert, T.Y. / Haraf, D.J. / Cohen, E.E.W. / Stenson, K. / Witt, M.E. / Dekker, A. / Kocherginsky, M. / Weichselbaum, R.R. / Chen, H.X. / Vokes, E.E. et al. | 2008
- 1742
-
Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human CancerKumar, A. / Petri, E.T. / Halmos, B. / Boggon, T.J. et al. | 2008
- 1752
-
Widespread Metastases After Resection of Noninvasive ThymomaGamboa, E.O. / Sawhney, V. / Lanoy, R.S. / Haller, N.A. / Powell, A.T. / Hazra, S.V. et al. | 2008
- 1755
-
Colon Cancer 15 Years After UreterosigmoidostomyChan, C.C.W. / Tan, A. / Salman, H. et al. | 2008
- 1757
-
Value of Cytogenetic Analysis in the Treatment of Dermatofibrosarcoma ProtuberansKerob, D. / Pruvost, C. / Lebbe, C. / Leboeuf, C. / Verola, O. / Janin, A. / Pedeutour, F. / de Kerviler, E. / Servant, J.M. / Sarandi, F. et al. | 2008
- 1760
-
The SentinelCampbell, B.H. et al. | 2008
- 1762
-
Missed Opportunities: Commentary on ``The Sentinel''Moynihan, T.J. / von Gunten, C.F. et al. | 2008
- 1764
-
Modification of Tamoxifen Response: What Have We Learned?Lash, T.L. / Ahern, T.P. / Cronin-Fenton, D. / Garne, J.P. / Hamilton-Dutoit, S. / Kvistgaard, M.E. / Rosenberg, C.L. / Silliman, R.A. / Sorensen, H.T. et al. | 2008
- 1766
-
Ethnic Considerations in Pharmacogenetic StudiesBranford, R.A. / Pantelidis, P. / Ross, J.R. et al. | 2008
- 1768
-
In Early-Stage Breast Cancer, the Estrogen Receptor Interacts With Correlation Between Human Epidermal Growth Factor Receptor 2 Status and Age at Diagnosis, Tumor Grade, and Lymph Node InvolvementNeven, P. / Brouckaert, O. / Van Belle, V. / Bempt, I.V. / Hendrickx, W. / Cho, H. / Deraedt, K. / Van Calster, B. / Van Huffel, S. / Moerman, P. et al. | 2008
- 1771
-
Prognostic Role of CA-125 Nadir in Stage IV Epithelial Ovarian CancerPrat, A. / Parera, M. / Del Campo, J.M. et al. | 2008
-
Breaking the Cure BarrierHolland, J.F. et al. | 2008